Moderna Cash from Operations (Quarterly) Analysis

Moderna Inc (MRNA)

53.54 -1.09 (-2.00%) USD | NASDAQ | Nov 04, 16:00

53.64 +0.10 (+0.19%) Pre-Market: 08:51

Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
June 30, 2024	-1.274B
March 31, 2024	-989.00M
December 31, 2023	622.00M
September 30, 2023	-1.60B
June 30, 2023	-915.00M
March 31, 2023	-1.225B
December 31, 2022	1.662B
September 30, 2022	252.00M
June 30, 2022	304.00M
March 31, 2022	2.763B
December 31, 2021	3.31B
September 30, 2021	3.276B
June 30, 2021	4.063B

Date	Value
March 31, 2021	2.971B
December 31, 2020	1.264B
September 30, 2020	893.00M
June 30, 2020	-24.00M
March 31, 2020	-106.00M
December 31, 2019	-99.05M
September 30, 2019	-107.09M
June 30, 2019	-108.58M
March 31, 2019	-144.27M
December 31, 2018	-91.02M
September 30, 2018	-80.21M
June 30, 2018	-48.25M
March 31, 2018	-111.38M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

-1.60B

Minimum

Sep 2023

4.063B

Maximum

Jun 2021

797.26M

Average

304.00M

Median

Jun 2022

Cash from Operations (Quarterly) Benchmarks

Eli Lilly and Co	3.712B
Merck & Co Inc	5.637B
Pfizer Inc	-1.781B
Novavax Inc	314.27M
Amgen Inc	3.571B

Cash from Operations (Quarterly) Related Metrics

Cash from Investing (Quarterly)	1.649B
Cash from Financing (Quarterly)	34.00M
Free Cash Flow	-3.979B
Free Cash Flow Per Share (Quarterly)	-3.792
Free Cash Flow to Equity (Quarterly)	-1.456B
Free Cash Flow to Firm (Quarterly)	-1.456B
Free Cash Flow Yield	-19.44%